Nitric oxide releasing poly(vinylidene fluoride-co-hexafluoropropylene) films using a fluorinated nitric oxide donor to greatly decrease chemical leaching
Source abstract
Abstract
Nitric oxide (NO) releasing polymers have been widely applied as biomaterials for a variety of biomedical implants and devices. However, the chemical leaching of NO donors and their byproduct species is almost always observed during the application of polymers doped with NO donors, unless the donor is covalently linked to the polymer. Herein, we report the first NO releasing poly(vinylidene fluoride-co-hexafluoropropylene) (PVDF-HFP) fluorinated copolymer prepared by incorporating a fluorinated S-nitrosothiol as the NO donor. Under physiological conditions, the resulting polymeric films can release NO for 16 days. Importantly, due to both fluorine-fluorine and electrostatic charge interactions between the fluorinated NO donor and the PVDF-HFP copolymer, the total chemical leaching of the fluorinated NO donor and its disulfide product after 9 day was only 0.6% (mol%) of the initial amount of NO donor loaded into the film. These new NO release PVDF-HFP films exhibit antimicrobial and anti-biofilm activities against both Gram positive S. aureus and Gram negative P. aeruginosa strains. The NO-releasing PVDF-HFP polymer can also be coated on Teflon tubing to release NO under physiological conditions for extended time periods. This NO-releasing PVDF-HFP copolymer with greatly reduced chemical leaching could help enhance the biocompatibility and antimicrobial activity of various biomedical devices. STATEMENT OF SIGNIFICANCE: Fluoropolymers have been widely used in creating various biomedical implants and devices. However, nitric oxide (NO) release fluoropolymers have not been well studied to date. Additionally, in the application of biomaterials doped with NO donors, a significant amount of NO donors and their byproducts almost always leach into aqueous environment. We now report an NO releasing poly(vinylidene fluoride-co-hexafluoropropylene) (PVDF-HFP) fluoropolymer by incorporating a new fluorinated S-nitrosothiol. The NO release can last for 16 days under physiological conditions. The total chemical leaching was determined to be only 0.6 mol% of the initial S-nitrosothiol loaded. As expected, significant antimicrobial/anti-biofilm activities of the NO release PVDF-HFP film were observed against Gram positive S. aureus and Gram negative P. aeruginosa bacterial strains.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced Sensor and Energy Harvesting Materials · Electrospun Nanofibers in Biomedical Applications · Silicone and Siloxane Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (50)
Show source-provided references
1. Applications of synthetic polymers in clinical medicine10.1016/j.bsbt.2015.08.002 ↗
2. Polymeric biomaterials for medical implants and devices10.1021/acsbiomaterials.5b00429 ↗
3. Ebnesajjad · 2017 · 193
4. Endothelial cell recovery, acute thrombogenicity, and monocyte adhesion and activation on fluorinated copolymer and phosphorylcholine polymer stent coatings10.1016/j.biomaterials.2009.09.079 ↗
5. Clinical implications of blood-material interaction and drug eluting stent polymers in review10.1080/17434440.2017.1363646 ↗
6. One year clinical follow-up of the XIENCE V Everolimus-eluting stent system in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II study10.4244/EIJV3I3A58 ↗
7. Xience V™ everolimus-eluting coronary stent10.1586/erd.09.1 ↗
8. Fluorinated polymers as smart materials for advanced biomedical applications10.3390/polym10020161 ↗
9. A clinical evaluation of the XIENCE V everolimus eluting stent in the treatment of patients with coronary artery disease: result from Thailand Registry – XIENCE V performance evaluation (THRIVE study)10.1016/j.ihj.2016.10.008 ↗
10. Drug-eluting stents to prevent stent thrombosis and restenosis10.1586/14779072.2016.1112267 ↗
11. XIENCE V™ stent design and rationale10.1111/j.1540-8183.2009.00450.x ↗
12. Blood compatibility assessment of polymers used in drug eluting stent coatings10.1116/1.4944586 ↗
13. Fabrication and characterisation of an electrospun tubular 3D scaffold platform of poly(vinylidene fluoride-co-hexafluoropropylene) for small-diameter blood vessel application10.1080/09205063.2014.968018 ↗
14. Evaluation of chemical stability of polymers of XIENCE everolimus-eluting coronary stents in vivo by pyrolysis-gas chromatography/mass spectrometry10.1002/jbm.b.33979 ↗
15. Interaction of platelets with poly(vinylidene fluoride-co-hexafluoropropylene) electrospun surfaces10.1021/bm4015396 ↗
16. Impact of polymer hydrophilicity on biocompatibility: Implication for DES polymer design10.1002/jbm.a.32057 ↗
17. In vivo wound healing and antibacterial performances of electrospun nanofibre membranes10.1002/jbm.a.32718 ↗
18. Bacterial adhesion, cell adhesion and biocompatibility of nafion films10.1163/156856208X386273 ↗
19. Superhydrophobic PVDF and PVDF-HFP nanofibrous mats with antibacterial and anti-biofouling properties10.1016/j.apsusc.2015.12.049 ↗
20. A review of the recent advances in antimicrobial coatings for urinary catheters10.1016/j.actbio.2016.11.070 ↗
21. Recent advances in thromboresistant and antimicrobial polymers for biomedical applications: just say yes to nitric oxide (NO)10.1039/C6BM00271D ↗
22. Recent advances in nitric oxide delivery for antimicrobial applications using polymer-based systems10.1039/C8TB00299A ↗
23. Nitric oxide-releasing macromolecular scaffolds for antibacterial applications10.1002/adhm.201800155 ↗
24. Characterization and in vivo performance of nitric oxide-releasing extracorporeal circuits in a feline model of thrombogenicity10.1002/jbm.a.35932 ↗
25. Attenuation of thrombosis and bacterial infection using dual function nitric oxide releasing central venous catheters in a 9 day rabbit model10.1016/j.actbio.2016.08.009 ↗
26. Diazeniumdiolate-doped poly(lactic-co-glycolic acid)-based nitric oxide releasing films as antibiofilm coatings10.1016/j.biomaterials.2012.07.027 ↗
27. Synthesis and characterization of the novel nitric oxide (NO) donating compound, S-nitroso-N-acetyl-d-penicillamine derivatized cyclam (SNAP-cyclam)10.1021/acsami.5b12548 ↗
28. Fabrication and characterization of a nitric oxide-releasing nanofibrous gelatin matrix10.1021/bm301984w ↗
29. Improved hemocompatibility of silicone rubber extracorporeal tubing via solvent swelling-impregnation of S-nitroso-N-acetylpenicillamine (SNAP) and evaluation in rabbit thrombogenicity model10.1016/j.actbio.2016.04.025 ↗
30. The preparation and characterization of nitric oxide releasing silicone rubber materials impregnated with S-nitroso-tert-dodecyl mercaptan10.1039/C5TB01664A ↗
31. Liquid-infused nitric oxide-releasing (LINORel) silicone for decreased fouling, thrombosis, and infection of medical devices10.1038/s41598-017-14012-9 ↗
32. Reduced foreign body response at nitric oxide-releasing subcutaneous implants10.1016/j.biomaterials.2007.06.036 ↗
33. Nitric oxide-releasing semi-crystalline thermoplastic polymers: preparation, characterization and application to devise anti-inflammatory and bactericidal implants10.1039/C8BM00849C ↗
34. Nitric oxide-releasing silica nanoparticle-doped polyurethane electrospun fibers10.1021/am402044s ↗
35. Blood coagulation response and bacterial adhesion to biomimetic polyurethane biomaterials prepared with surface texturing and nitric oxide release10.1016/j.actbio.2018.11.035 ↗
36. Nitric oxide releasing tygon materials: studies in donor leaching and localized nitric oxide release at a polymer-buffer interface10.1021/am402112y ↗
37. Plasma-modified nitric oxide-releasing polymer films exhibit time-delayed 8-log reduction in growth of bacteria10.1116/1.4959105 ↗
38. Origin of long-term storage stability and nitric oxide release behavior of CarboSil polymer doped with S-nitroso-N-acetyl-d-penicillamine10.1021/acsami.5b07501 ↗
39. A multi-defense strategy: enhancing bactericidal activity of a medical grade polymer with a nitric oxide donor and surface-immobilized quaternary ammonium compound10.1016/j.actbio.2017.05.061 ↗
40. Enhanced antibacterial efficacy of nitric oxide releasing thermoplastic polyurethanes with antifouling hydrophilic topcoats10.1039/C6BM00948D ↗
41. Reduction of thrombosis and bacterial infection via controlled nitric oxide (NO) release from S-nitroso-N-acetylpenicillamine (SNAP) impregnated CarboSil intravascular catheters10.1021/acsbiomaterials.6b00622 ↗
42. Synthesis and characterization of a fluorinated S-nitrosothiol as the nitric oxide donor for fluoropolymer-based biomedical device applications10.1039/C8TB01814F ↗
43. Synthesis and nitric oxide releasing properties of novel fluoro S-nitrosothiols10.1039/C8CC08868C ↗
44. Synthesis, spectroscopy, and stability of the nitric oxide donor S-nitroso-N-acetylpenicillamine: an undergraduate laboratory experiment
45. Further evidence on the importance of fluorous-fluorous interactions in supramolecular chemistry: a combined structural and computational study10.1021/acs.cgd.5b00254 ↗
46. Organic fluorine compounds: a great opportunity for enhanced materials properties10.1039/c0cs00221f ↗
47. Fluorine in crystal engineering-“the little atom that could”10.1039/B406892K ↗
48. Efficient eradication of mature Pseudomonas aeruginosa biofilm via controlled delivery of nitric oxide combined with antimicrobial peptide and antibiotics10.3389/fmicb.2016.01260 ↗
49. Biodegradable nitric oxide-releasing poly(diol citrate) elastomers10.1002/jbm.a.32536 ↗
50. NO-loaded Zn2+-exchanged zeolite materials: a potential bifunctional anti-bacterial strategy10.1016/j.actbio.2009.10.038 ↗